Dominic Bukenya & Mayanja Billy Nsubuga
Dominic Bukenya is a social scientist based at a rural south western Uganda field station for the Medical Research Council /Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine Uganda Research Unit. Over the last decade, Dominic has been involved in and leading designing and implementation of epidemiological and behavioural research projects. He has also been involved and leading on data management and analysis, resulting peer reviewed journal articles and conference papers for national and international dissemination.
Dr. Mayanja Billy Nsubuga is an Epidemiologist and a Senior Scientist at the MRC/UVRI and LSHTM Uganda Research Unit. For over two decades, Dr. Mayanja has worked as a Research Medical Officer and Project Leader on several epidemiological studies including the Complications of Long-Term Antiretroviral Therapy (CoLTART) study. His roles included provision of participants’ medical care including antiretroviral therapy, designing and implementation of several clinical / epidemiological studies. On several research studies, he has participated in data analysis and manuscript write up for publication in peer reviewed journals and presentation at national and international scientific conferences and meetings.
Dr. Mayanja Billy Nsubuga is an Epidemiologist and a Senior Scientist at the MRC/UVRI and LSHTM Uganda Research Unit. For over two decades, Dr. Mayanja has worked as a Research Medical Officer and Project Leader on several epidemiological studies including the Complications of Long-Term Antiretroviral Therapy (CoLTART) study. His roles included provision of participants’ medical care including antiretroviral therapy, designing and implementation of several clinical / epidemiological studies. On several research studies, he has participated in data analysis and manuscript write up for publication in peer reviewed journals and presentation at national and international scientific conferences and meetings.
What stops people with HIV adhering to long term antiretroviral therapy?
Long term adherence to antiretroviral therapy (ART) is important in both reducing morbidly and mortality in people living with HIV and reducing transmission rates. A new study published in AIDS Research and Therapy explores people’s reasons for non-adherence to ART through a cohort in Uganda. They find travel, stigma, poor adherence education, and alternative medicine to be prominent factors.
Over the last one and half decades, we have witnessed wide spread antiretroviral therapy (ART) use in HIV care and treatment. ART use has greatly reduced morbidity and mortality among people living with HIV, and subsequently improved life expectancy and quality of life. ART use also reduces the HIV transmission risk through the resultant HIV viral suppression.
.png)
No hay comentarios:
Publicar un comentario